MedPath

Residual or Recurrent Obstruction After Septal Myectomy

Completed
Conditions
Hypertrophic Obstructive Cardiomyopathy
Registration Number
NCT05687487
Lead Sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital
Brief Summary

The goal of this observational study is to report the outcomes after septal myectomy in young children and infants and identify the mechanisms of residual or recurrent obstruction after surgery. in The main question\[s\] it aims to answer are:

* What is the early and mid-term results of septal myectomy in young children and infants with severe and extensive obstructive hypertrophic cardiomyopathy (HCM)?

* What are the mechanisms of residual or recurrent obstruction?

Echocardiography and clinical course of children and infants under the age of 14 who underwent septal myectomy for hypertrophic obstructive cardiomyopathy from January 2013 to December 2020 will be followed up.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
56
Inclusion Criteria
  • Clinical diagnosis of hypertrophic obstructive cardiomyopathy (HOCM)
  • Age young than 14 years
  • Patients who have undergone septal myectomy
Exclusion Criteria
  • older than 14 years old;
  • secondary left ventricular hypertrophy (LVH) related to subaortic stenosis or aortic stenosis.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
deaththrough study completion, an average of 1 year

postoperative death during follow-up

Secondary Outcome Measures
NameTimeMethod
recurrent obstructionthrough study completion, an average of 1 year

postoperative recurrent obstruction during follow-up

© Copyright 2025. All Rights Reserved by MedPath